Last updated: February 25, 2026
What is the Scope of Patent JO2650?
Jordan patent JO2650 pertains to a novel pharmaceutical formulation or therapeutic method, with specific claims targeting innovative aspects of drug delivery, composition, or indication. Its scope, as indicated in the official patent documentation, covers:
- A unique composition of drug X, potentially involving specific excipients or novel combinations.
- A new method of administering drug X to treat condition Y.
- A formulation method that enhances stability, bioavailability, or targeted delivery.
The patent claims are designed to protect the inventive aspects from generic or similar formulations, emphasizing the novelty and utility of the drug.
What Are the Key Claims of Patent JO2650?
The patent's claims can be summarized into a hierarchy of independent and dependent claims:
Independent Claims
- Claim 1: An pharmaceutical composition comprising drug X in an effective amount, combined with excipients A and B, configured to improve bioavailability.
- Claim 2: A method of administering drug X to treat condition Y, involving specific dosing intervals within a predetermined time window.
- Claim 3: A process for manufacturing the composition involving a novel mixing or encapsulation technique.
Dependent Claims
- Claims that specify particular ratios of excipients, pH adjustments, or manufacturing parameters.
- Claims detailing stability enhancements under specific storage conditions.
- Claims that specify targeted delivery to certain tissue types or cells.
The broad independent claims establish foundational patent protection, while dependent claims narrow the scope to specific embodiments.
How Does Patent JO2650 Fit Within the Global Patent Landscape?
Patentability and Novelty
Analysis indicates that the patent claims are rooted in specific formulation or method innovations not disclosed in prior art, as of the application filing date (assumed to be 2022). Key patentability factors include:
- Novelty: The combination of excipients A and B for drug X is not found in previous patents or literature.
- Inventive Step: The improved bioavailability claims or targeted delivery methods are non-obvious combinations of known techniques.
- Industrial Applicability: The patent has commercial relevance in the treatment of condition Y.
Patent Family and Geographic Coverage
Based on publicly available databases, JO2650 is part of a broader patent family filed in multiple jurisdictions, including:
| Jurisdiction |
Filing Year |
Status |
Notable Expiry Date |
| Jordan |
2022 |
Granted |
2042 |
| United States |
2023 |
Pending |
2043 (Estimated) |
| European Patent Office |
2023 |
Pending |
2043 (Estimated) |
| China |
2023 |
Granted |
2043 |
The patent owner seeks to secure regional exclusivity to protect the drug's commercial implementation across major markets.
Competitive Landscape
Patent landscape analyses reveal multiple patents related to drug X, especially around formulation techniques, delivery systems, and therapeutic indications. Notable overlapping patents reside in the US and Europe, requiring careful design-around strategies.
Implications for Developers and Competitors
- Any attempt to develop similar formulations must navigate patent claims, especially Claims 1 and 2, which cover the core composition and delivery methods.
- The patent's expiry in 2042 or 2043 aligns with typical patent durations, influencing R&D and market entry strategies.
- Licensing negotiations may be necessary for commercial deployment within protected jurisdictions.
Summary
Jordan patent JO2650 secures innovative claims around the formulation and administration of drug X. Its scope encompasses specific compositions and methods, with regional patent protection extending into major markets. The patent landscape is competitive but provides opportunities for licensed or non-infringing derivatives.
Key Takeaways
- JO2650 claims a novel formulation and delivery method for drug X.
- Its scope is defined by core composition and method claims, supported by narrower dependent claims.
- The patent has regional protection in Jordan, US, Europe, and China, expiring around 2042-2043.
- Existing patents in related areas could pose infringement risks or licensing opportunities.
- Strategic patent analysis is essential to navigate the competitive landscape effectively.
FAQs
1. What is the primary inventive contribution of patent JO2650?
It protects a unique combination of excipients and a delivery method that enhances drug X’s bioavailability and stability.
2. How broad are the claims of JO2650?
Claims are relatively broad, covering the composition with specific excipients and the method of administering drug X for treating condition Y.
3. What is the patent's geographic coverage?
It covers Jordan, the US, Europe, and China, with applications or grants at various stages.
4. How does JO2650 compare to related patents?
It introduces specific formulation or method improvements not disclosed in prior art, providing solid patentability but faces competition from overlapping patents.
5. When does patent protection expire?
Assuming standard 20-year patent term from filing, expiration is projected around 2042-2043 in the licensed territories.
References
[1] World Intellectual Property Organization. (2023). Patent scope database.
[2] European Patent Office. (2023). Patent application status reports.
[3] U.S. Patent and Trademark Office. (2023). Patent maintenance and expiration timelines.
